genae Appoints Chief Medical Officer

ANTWERP, Belgium, April 26, 2016 /PRNewswire/ --

genae, a Contract Research Organization (CRO) and services provider for the medical industries, announced today the appointment of Prof. Dr. Jörn Balzer to the role of Chief Medical Officer. Prof. Balzer’s responsibilities will include all clinical, safety and risk management related to genae’s research services.

“We feel privileged and honored with the acceptance of Prof. Balzer to join our team,” said Bart Segers, CEO at genae. “Prof. Balzer’s impressive and extensive background make him a perfect fit for the genae team, as his extensive clinical and research expertise will play a key role in helping us to achieve our goals and strategic priorities.”

Prof. Balzer is Head Physician and Medical Director at the Katholische Klinikum Mainz, Germany. Previously, he was Assistant Medical Director at the Klinikum der Johann Wolfgang Goethe Universität in Frankfurt Am Main, Director at the Universitätsklinikum des Saarlandes in Homburg /Saar, and Intern at the Charité Campus Virchow Klinikum in Berlin. His scientific and research work is illustrated by peer-reviewed publications and presentations during international congresses and symposia.

About the genae group

genae is involved in the development and commercialization of medical devices, biologics and therapies that change medical practice. genae is a full service CRO and services provider for the medical industries and aims at improving health and quality of life by innovating and accelerating high quality research. The group’s Quality Management System has been tested rigorously and continues to pass regulatory and sponsor’s audits and inspections.

genae associates nv is a privately held company with principal offices in Antwerp, Belgium and is part of the genae group, the medical device CRO.

To learn more about genae, please visit http://www.genae.com.

Contact

genae associates nv
Bart Segers, CEO
+32-3-290-03-06
Justitiestraat 6B, 2018 Antwerp, Belgium
bart.segers@genae.com

MORE ON THIS TOPIC